Literature DB >> 7589846

Low birth weight. A risk factor for development of diabetic nephropathy?

P Rossing1, L Tarnow, F S Nielsen, B V Hansen, B M Brenner, H H Parving.   

Abstract

It has been demonstrated that intrauterine growth retardation, defined as birth weight below the 10th percentile, gives rise to a reduction in nephron number. Oligonephropathy has been suggested to increase the risk for systemic and glomerular hypertension in adult life as well as enhance risk for expression of renal disease after exposure to potentially injurious renal stimuli. The aim of this study was to determine if low birth weight is a risk factor for development of diabetic nephropathy. In a case-control study, we investigated 184 (110 men) insulin-dependent diabetes mellitus (IDDM) patients with diabetic nephropathy (persistent albuminuria > 300 mg/24 h) (age [mean +/- SD] 41.0 +/- 9.3 years, duration of diabetes 26.9 +/- 8.2 years) and 182 (111 men) normoalbuminuric (< 30 mg/24 h) IDDM patients (age 42.1 +/- 9.8 years, duration of diabetes 25.8 +/- 8.6 years). Information about weight at birth was obtained from the midwife's original registrations. In women below the 10th percentile in birth weight (< or = 2,700 g, n = 16), 75% had nephropathy compared with only 35% among patients whose birth weights were above the 90th percentile (> or = 4,000 g, n = 17) (P = 0.05). In men below the 10th percentile in birth weight (< or = 2,910 g, n = 22), the prevalence of patients with nephropathy (50%) was similar to the prevalence among patients above the 90th percentile in birth weight (> or = 4,200 g, n = 24) (54%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7589846     DOI: 10.2337/diab.44.12.1405

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  Telomeres and telomerase in the fetal origins of cardiovascular disease: a review.

Authors:  Ellen W Demerath; Noel Cameron; Matthew W Gillman; Bradford Towne; Roger M Siervogel
Journal:  Hum Biol       Date:  2004-02       Impact factor: 0.553

Review 2.  The clinical significance of hyperfiltration in diabetes.

Authors:  G Jerums; E Premaratne; S Panagiotopoulos; R J MacIsaac
Journal:  Diabetologia       Date:  2010-05-23       Impact factor: 10.122

Review 3.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

4.  The prevalence of coeliac disease in adult Danish patients with type 1 diabetes with and without nephropathy.

Authors:  H Skovbjerg; L Tarnow; H Locht; H-H Parving
Journal:  Diabetologia       Date:  2005-05-26       Impact factor: 10.122

Review 5.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

6.  Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.

Authors:  P Rossing
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

7.  Effect of prenatal dexamethasone on rat renal development.

Authors:  L A Ortiz; A Quan; A Weinberg; M Baum
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

8.  Detection and Clinical Patterns of Nephron Hypertrophy and Nephrosclerosis Among Apparently Healthy Adults.

Authors:  Aleksandar Denic; Mariam P Alexander; Vidhu Kaushik; Lilach O Lerman; John C Lieske; Mark D Stegall; Joseph J Larson; Walter K Kremers; Terri J Vrtiska; Harini A Chakkera; Emilio D Poggio; Andrew D Rule
Journal:  Am J Kidney Dis       Date:  2016-02-06       Impact factor: 8.860

9.  Birth weight [corrected] and elevated albumin to creatinine ratio in youth with diabetes: the SEARCH for Diabetes in Youth study.

Authors:  David M Maahs; Beverly M Snively; Jennifer Beyer; Giuseppina Imperatore; Ronny Bell; Elizabeth J Mayer-Davis; Lawrence M Dolan; David J Pettitt; Irl Hirsch; Beatriz Rodriguez; Dana Dabelea
Journal:  Pediatr Nephrol       Date:  2008-07-08       Impact factor: 3.714

10.  Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.

Authors:  Johan Wadén; Carol Forsblom; Lena M Thorn; Markku Saraheimo; Milla Rosengård-Bärlund; Outi Heikkilä; Kustaa Hietala; Ken Ong; Nicholas Wareham; Per-Henrik Groop
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.